|
EPB41L4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81859999998291E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.88080000000413E-05 |
| Normal-vs-Stage2 |
8.177900E-02 |
| Normal-vs-Stage3 |
1.310220E-01 |
| Normal-vs-Stage4 |
7.612400E-01 |
| Stage1-vs-Stage2 |
9.232400E-01 |
| Stage1-vs-Stage3 |
4.089600E-01 |
| Stage1-vs-Stage4 |
2.337800E-01 |
| Stage2-vs-Stage3 |
5.049600E-01 |
| Stage2-vs-Stage4 |
2.976400E-01 |
| Stage3-vs-Stage4 |
4.940200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82488000000092E-05 |
| Normal-vs-AfricanAmerican |
2.232000E-02 |
| Normal-vs-Asian |
4.467800E-01 |
| Caucasian-vs-AfricanAmerican |
6.108400E-01 |
| Caucasian-vs-Asian |
9.799400E-01 |
| AfricanAmerican-vs-Asian |
8.601600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.52910000003914E-06 |
| Normal-vs-Female |
8.039000E-03 |
| Male-vs-Female |
8.033600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.162800E-01 |
| Normal-vs-Extreme_Weight |
2.338900E-03 |
| Normal-vs-Obese |
3.958000E-03 |
| Normal-vs-Extreme_Obese |
5.385500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.923440E-01 |
| Normal_Weight-vs-Obese |
1.209230E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.364370E-01 |
| Extreme_Weight-vs-Obese |
5.353000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.829600E-01 |
| Obese-vs-Extreme_Obese |
7.032200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.383000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.06530000004912E-06 |
| Normal-vs-Age(61-80Yrs) |
2.935900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.897700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.578200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.571200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.006200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.853500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.512600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.88319999997411E-07 |
| Normal-VS-Type2 PRCC |
7.980800E-03 |
| Normal-VS-KIRP CIMP |
9.042400E-03 |
| Normal-VS-Unclassified PRCC |
1.481150E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.986200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.06730000000111E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.347000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.220500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.571380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.25120000000501E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.802180E-02 |
| Normal-vs-N1 |
1.805170E-01 |
| Normal-vs-N2 |
8.418400E-02 |
| N0-vs-N1 |
6.107200E-01 |
| N0-vs-N2 |
1.446040E-01 |
| N1-vs-N2 |
1.695600E-01 |
|
|
